4Suppliers
1Customers
2Debt Items
20Related Chains

Beam Therapeutics Inc. Suppliers

TickerNameConfidenceEvidence
KOBE-UNIVERSITY KOBE-UNIVERSITY 85% Bio Palette licensed directly from Kobe University
LLY Eli Lilly and Company 72% Reciprocal relationship from LLY graph: 8,190.0 $ 14,667.5 $ 12,333.1 $ 10,351.3 Numbers may not add due to rounding. (1) Jardiance revenue includes Glyxambi, Synjardy, and Trijardy XR. (2) Humalog r…
PRME Prime Medicine, Inc. 72% Reciprocal relationship from PRME graph: orm is expected to allow Prime Medicine to generate follow-on candidates rapidly and efficiently. In addition, we are identifying partnership opportunities to…
SANA Sana Biotechnology, Inc. 72% Reciprocal relationship from SANA graph: Reciprocal relationship from BEAM graph: Reciprocal relationship from SANA graph: Reciprocal relationship from BEAM graph: Reciprocal relationship from SANA g…

Beam Therapeutics Inc. Customers

TickerNameConfidenceEvidence
SANA Sana Biotechnology, Inc. 72% Reciprocal relationship from SANA graph: the University of California (UCSF), our fusogen technology that we acquired from Cobalt Biomedicine, Inc. (Cobalt), and gene editing technology that we licen…

Beam Therapeutics Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
BEAM-DEBT-8131 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.
BEAM-DEBT Debt stack $250.8M 90% Market cache reports total debt of $250.8M.

Beam Therapeutics Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Beam Therapeutics Inc..

Beam Therapeutics Inc. Ownership

HolderNameConfidenceEvidence
BEAM-OWNER-FMR-LLC FMR LLC 90% 13F overlay lists FMR LLC as top holder; 254 tracked holders.

Beam Therapeutics Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
HOWL Werewolf Therapeutics, Inc. 100.00 2
KRRO Korro Bio, Inc. 100.00 2
DRTS Alpha Tau Medical Ltd. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
JANX Janux Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
EDIT Editas Medicine, Inc. 100.00 1 ['receiving']
EMMA Emmaus Life Sciences, Inc. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
IBIO iBio, Inc. 100.00 2
TLSA Tiziana Life Sciences Ltd 100.00 2
CPMV Mosaic ImmunoEngineering, Inc. 100.00 2
CHRS Coherus Oncology, Inc. 100.00 2
CLLS Cellectis S.A. 100.00 2
GRFS Grifols, S.A. 100.00 2
BMY Bristol-Myers Squibb Company 100.00 1 ['receiving']
BMYMP Bristol-Myers Squibb Co 100.00 1 ['receiving']
KRYS Krystal Biotech, Inc. 100.00 2